У нас вы можете посмотреть бесплатно Why promising Alzheimer’s drug news doesn’t always mean a cure или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Why promising Alzheimer’s drug news doesn’t always mean a cure You may have heard about a diabetes drug called liraglutide being tested in Alzheimer’s — and it didn’t produce dramatic brain effects in a large, year-long trial of people with mild–moderate disease. PubMed Here’s what that really means — and why it fits the bigger picture in Elusive Cures: 🔬 Early lab hope doesn’t always translate to real brains In animals and cell models, liraglutide seemed protective for brain cells. But when tested in hundreds of people, it didn’t significantly change key brain metabolism measurements — though small cognitive hints were seen. PubMed ⏱ Timing matters Just like many Alzheimer’s trials, this study enrolled people after symptoms were already clear. But brain diseases develop for years or decades before symptoms show — so by the time you treat, the disease may be too advanced for single-target drugs to move the needle. This idea is a core theme in Elusive Cures: many negative trials aren’t because researchers failed — they show that one-pathway treatments started late often aren’t enough. 🔄 Good science builds knowledge even when drugs “fail” This study found the drug was safe and well-tolerated in people without diabetes — a useful piece of scientific info itself. Growing evidence like this helps researchers refine when, who, and how to treat, rather than giving up. PubMed 🏁 Real progress is complex and takes time Just like Elusive Cures explains, breakthroughs in brain disease aren’t usually overnight. They require: ✨ earlier detection ✨ better matching of biology to treatment ✨ new ways to measure meaningful benefit So next time a study doesn’t show a “cure,” remember: it’s part of the path forward, not proof that progress has stopped. #BrainHealth #Alzheimers #ScienceExplained #ClinicalTrials #HopeThroughScience Reference https://pubmed.ncbi.nlm.nih.gov/41326... Connect further with Dr Ann Conn: Website: https://www.annconnmd.com Register for my free webinar: Reversing Chronic Migraine: Your Path to Real Recovery Starts Here: https://annconnmd.mykajabi.com/Preven... Learn At Pinnacle & Earn CME: https://learnatpinnacle.com/education Subscribe to newsletter: https://annconnmd.activehosted.com/f/7 Youtube: / @annconnmd Instagram: / annconnmd Facebook: https://www.facebook.com/profile.php?... The Conn Job Podcast: https://podcasts.apple.com/us/podcast...